ArticleMucosal immunology2023
GL7 ligand expression defines a novel subset of CD4
Open access · hybridAbstract read
In one paragraph
Article in Mucosal immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 6 citations in OpenAlex.
- PD-1 Inhibits CD4+ TRM-Mediated cDC1 Mobilization via Suppressing JAML in Human NSCLC.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Limosilactobacillus reuteri Strains Differentially Stimulate Immunity in Response to Human Milk Oligosaccharides in Newborn Mice.Probiotics and antimicrobial proteins · 2026Article
- Tissue-resident immune cells: from defining characteristics to roles in diseases.Signal transduction and targeted therapy · 2025Review
- B cells in the pneumococcus-infected lung are heterogeneous and require CD4Frontiers in immunology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors at 2 institutions in 1 country.
Carolina Lyon De AnaPulmonary Center, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA; Department of Virology, Immunology, & Microbiology, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA.
Anukul T ShenoyPulmonary Center, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA; Department. of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Kimberly A BarkerPulmonary Center, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA; Department of Virology, Immunology, & Microbiology, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA.
Emad I ArafaPulmonary Center, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA; Department of Medicine, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA.
Neelou S EtesamiPulmonary Center, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA; Department of Virology, Immunology, & Microbiology, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA.
Filiz T KorkmazPulmonary Center, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA; Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
Alicia M SoucyPulmonary Center, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA.
Michael P BreenPulmonary Center, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA; Department of Virology, Immunology, & Microbiology, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA.
Ian M C MartinPulmonary Center, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA.
Brian R TiltonPulmonary Center, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA.
Priyadharshini DevarajanDepartment of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
Nicholas A CrosslandNational Emerging Infectious Diseases Laboratories, Boston University, Boston, Massachusetts, USA; Department of Pathology and Laboratory Medicine, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA.
Riley M F PihlPulmonary Center, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA; Department of Medicine, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA; Flow Cytometry Core Facility, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA.
Wesley N GoltryPulmonary Center, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA.
Anna C BelkinaPulmonary Center, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA; Flow Cytometry Core Facility, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA; Department of Pathology and Laboratory Medicine, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA.
Matthew R JonesPulmonary Center, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA; Department of Medicine, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA.
Lee J QuintonPulmonary Center, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA; Department of Virology, Immunology, & Microbiology, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA; Department of Medicine, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA; Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA; Department of Pathology and Laboratory Medicine, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA.
Joseph P MizgerdPulmonary Center, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA; Department of Virology, Immunology, & Microbiology, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA; Department of Medicine, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA; Department of Biochemistry & Cell Biology, Boston University Chobanian & Avedesian School of Medicine, Boston, Massachusetts, USA. Electronic address: jmizgerd@bu.edu.
Boston University · USUniversity of Massachusetts Chan Medical School · US
Funding
BIOLOGY OF THE LUNG--MULTIDISCIPLINARY PROGRAMT32HL007035 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Darrell N. Kotton, JOSEPH P MIZGERD · 1985 to 2026
$24.3MPneumonia BiologyR35HL135756 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MIZGERD, JOSEPH P · 2017 to 2023
$6.6MLung-resident antibacterial heterotypic immunityR01AI115053 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MIZGERD, JOSEPH P · 2015 to 2023
$4.0MThe Biology of LIF During PneumoniaR01HL111449 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI QUINTON, LEE · 2012 to 2020
$3.7MLOX-1 as a protective countermeasure in response to lung infectionR01HL165718 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Lee Quinton · 2023 to 2026
$3.0MThe B cell repertoire as a window into the nature and impact of the lung viromeR33HL137081 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FEARNS, RACHEL, KEPLER, THOMAS B · 2019 to 2021
$2.4MOrigins and functional roles of Miwi2-positive multiciliated cells during inflammationR01HL136725 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FINE, ALAN FINE, JONES, MATTHEW ROBERT · 2018 to 2021
$1.6MLiver-derived protection during pneumonia and sepsisR01GM120060 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI QUINTON, LEE · 2017 to 2020
$1.3MLung epithelial cell reprogramming by CD4 T cellsR00HL157555 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHENOY, ANUKUL T · 2023 to 2025
$747kVectra Polaris Quantitative Pathology Imaging SystemS10OD030269 · OD · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CROSSLAND, NICHOLAS ALEXANDER · 2021 to 2021
$402kLung epithelial cell reprogramming by CD4 T cellsK99HL157555 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI SHENOY, ANUKUL T · 2022 to 2023
$271kProtective lung memory B cell functions and dynamics during respiratory infectionF30HL158109 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ETESAMI, NEELOU · 2021 to 2024
$209kNHLBI NIH HHS F30 HL158109NHLBI NIH HHS F31 HL142199NHLBI NIH HHS F31 HL147397NHLBI NIH HHS F32 HL147461NHLBI NIH HHS K99 HL157555NHLBI NIH HHS R00 HL157555NHLBI NIH HHS R01 HL111449NHLBI NIH HHS R01 HL136725NHLBI NIH HHS R01 HL165718NHLBI NIH HHS R33 HL137081NHLBI NIH HHS R35 HL135756NHLBI NIH HHS T32 HL007035NIAID NIH HHS R01 AI115053NIGMS NIH HHS R01 GM120060NIH HHS S10 OD026983NIH HHS S10 OD030269
Abstract
Streptococcus pneumoniae is the most common etiology of bacterial pneumonia, one of the leading causes of death in children and the elderly worldwide. During non-lethal infections with S. pneumoniae, lymphocytes accumulate in the lungs and protect against reinfection with serotype-mismatched strains. Cluster of differentiation CD4
Indexed as
LungStreptococcus pneumoniaeAgedAnimalsAntigens, DifferentiationCD4-Positive T-LymphocytesChildHumansImmunologic MemoryLigandsMiceT-Lymphocytesantigen GL7Antigens, DifferentiationLigands
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.